[1]
A. Mjali, M. M. Obaid, B. F. Matti, and N. T. Abbas, “Treatment Outcomes of Nilotinib as Second Line Therapy for Chronic Myeloid Leukemia Patients in Karbala Province of Iraq”, Asian Pac J Cancer Care, vol. 7, no. 2, pp. 267–272, Jun. 2022.